Spots Global Cancer Trial Database for Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function
Official Title: Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function: A Chinese Multicenter Observational Study
Study ID: NCT06245785
Conditions
Interventions
Study Description
Brief Summary: Hepatic dysfunction limits the therapeutic options for hepatocellular carcinoma (HCC), which is closely associated with patient prognosis. Established practice guidelines for patients with HCC and impaired liver function are lacking. The treatment allocation in these populations is heterogeneous and remains controversial. This study compared the survival benefits of liver resection (LR) and transarterial chemoembolisation (TACE) in patients with HCC and impaired liver function.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tangdu hospital, Xian, Shaanxi, China
Xijing hospital, Xian, Shaanxi, China
Contact Details
Name: zhao s jie
Affiliation: Teachers and students
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
